日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Construction of a risk prediction model for premature rupture of membranes based on vaginal microecology and systemic inflammation: a prospective cohort study

基于阴道微生态和全身炎症的胎膜早破风险预测模型构建:一项前瞻性队列研究

Xu, Xiaoyan; Xu, Yuance; Zhen, Xuehui; Zhang, Jianguang; Li, Chenyang

Uncovering potential targets for antibody-drug conjugates in the treatment of gynecologic malignancies

揭示抗体药物偶联物在妇科恶性肿瘤治疗中的潜在靶点

Jiang, Yuying; Xu, Yuance; He, Junqi; Sui, Lei; Li, Tian; Xia, Nannan; Yao, Qin

The association of insulin resistance and obesity with uterine fibroids in non-diabetic populations: a cross-sectional study

胰岛素抵抗和肥胖与非糖尿病人群子宫肌瘤的关联:一项横断面研究

Sun, Danting; Liu, Haixia; Gao, Jiaze; Su, Yapei; Xu, Yuance; Lv, Teng

DHCR24 overexpression is involved in lipid metabolic reprogramming to drive cervical cancer malignant progression and is associated with immune microenvironment

DHCR24 过表达参与脂质代谢重编程,从而驱动宫颈癌的恶性进展,并且与免疫微环境相关。

Cheng, Lin; Xu, Yuance; Li, Zhuo; Sun, Danting; Xu, Yan; He, Junqi; Chen, Yulong; Yao, Qin

Cancer-associated fibroblasts in ovarian cancer: research progress

卵巢癌中的癌相关成纤维细胞:研究进展

Xu, Yuance; Sun, Danting; He, Junqi; Yao, Qin

Case Report: Strumal carcinoid tumor in the ovary: report of a rare occurrence with a review of literature

病例报告:卵巢间质类癌:一例罕见病例报告及文献复习

Zhu, Wei; Xu, Yuance; Yao, Qin

Injectable bio-multifunctional hyaluronic acid-based hydrogels loaded with poly ADP-ribose polymerase inhibitors for ovarian cancer therapy

可注射的生物多功能透明质酸基水凝胶,其中载有聚 ADP 核糖聚合酶抑制剂,用于卵巢癌治疗

Xiahui Han, Guotai Li, Shijing You, Meiyue Shen, Yuance Xu, Han Yang, Changyu Lu, Mingyun Zhang, Junqiang Fang, Qihui Zhou, Qin Yao

A novel strategy for spinal cord reconstruction via vascularized allogeneic spinal cord transplantation combine spinal cord fusion

一种通过带血管蒂的同种异体脊髓移植进行脊髓重建的新策略结合了脊髓融合术

Zhang, Weihua; Lan, Rongyu; Shen, Tingting; Qin, Jie; Wang, Zhihui; Chen, Jiayang; Wang, Jiaxing; Wu, Zhuotan; Xu, Yudong; Shen, Yangyang; Lin, Qikai; Chen, Yuan; Wei, Yi; Liu, Yiwen; Ning, Yuance; Zhou, Yiyan; Deng, Liji; Han, Linxuan; Wu, Xiaofei; Deng, Haixuan; Cao, Zhenbin; Yao, Xianping; Ren, Xiaoping

SLC45A4 is involved in malignant progression of ovarian cancer through glycolytic metabolic reprogramming

SLC45A4通过糖酵解代谢重编程参与卵巢癌的恶性进展

Yuance Xu, Xiahui Han, Shijing You, Wei Zhu, Mingyun Zhang, Changyu Lu, Junqi He, Qin Yao

High expression of SLC7A1 in high-grade serous ovarian cancer promotes tumor progression and is involved in MAPK/ERK pathway and EMT

高级别浆液性卵巢癌中SLC7A1高表达促进肿瘤进展并参与MAPK/ERK通路及EMT

Shijing You, Xiahui Han, Yuance Xu, Lei Sui, Kejuan Song, Qin Yao